Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/124018
Performance monitoring in lung cancer patients pre- and post-chemotherapy using fine-grained electrophysiological measures
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
No previous event-related potentials (ERPs) study has explored the error-related negativity (ERN) - an ERP component indexing performance monitoring - associated to cancer and chemotherapy-induced cognitive impairment in a lung cancer population. The aim of this study was to examine differences in performance monitoring in a small-cell lung cancer group (SCLC, C+) 1-month following chemotherapy and two control groups: a non-small cell lung cancer patient group (NSCLC, C-) prior to chemotherapy and a healthy control group (HC). Seventeen SCLC (C+) underwent a neuropsychological assessment and an ERP study using a flanker and a stop-signal paradigm. This group was compared to fifteen age-, gender-and education-matched NSCLC (C-) and eighteen HC. Between 20 and 30% of patients in both lung cancer groups (C+ and C-) met criteria for cognitive impairment. Concerning ERPs, lung cancer patients showed lower overall hit rate and a severe ERN amplitude reduction compared to HC. Lung cancer patients exhibited an abnormal pattern of performance monitoring thus suggesting that chemotherapy and especially cancer itself, may contribute to cognitive deterioration. ERN appeared as an objective laboratory tool sensitive to cognitive dysfunction in cancer population.
Subject
Subject (English)
Citation
Citation
SIMÓ PARRA, Marta, et al. Performance monitoring in lung cancer patients pre- and post-chemotherapy using fine-grained electrophysiological measures. NeuroImage: Clinical. 2018. Vol. 18, num. 86-96. [consulted: 9 of June of 2026]. Available at: https://hdl.handle.net/2445/124018